Article
Microbubbles: New Carrier for Chemotherapy Delivery
The study, conducted in pancreatic cancer patients in Norway, was presented at the annual meeting of the International Contrast Ultrasound Society in Chicago.
Tiny gas microbubbles may enhance the delivery and absorption of cancer drugs in patients with advanced pancreatic cancer, according to a pilot study described today at the International Contrast Ultrasound Society (ICUS) annual conference.
"Our early findings suggest that commercially-available ultrasound microbubbles, combined with a standard chemotherapy drug, may prolong survival in pancreatic cancer patients," according to Dr. Odd Helge Gilja, Head of National Centre of Ultrasound in Gastroenterology at Haukeland University Hospital, Chair of Research at Dept. Of Clinical Medicine at University of Bergen, Norway, and President-Elect of the European Federation of Ultrasound in Medicine and Biology.
The pilot study included 10 patients with inoperable tumors, and preliminary results showed that tumor size was reduced or growth was slowed in the patients, according to Dr. Gilja. Additional studies are planned to confirm and potentially extend the results, he said.
Read the complete article: http://on.mktw.net/1ukabge
Source: MarketWatch
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
